Ptc Therapeutics, Inc.

Anthony R Mazzotti

Gary Mitchell Karp

Suresh D Babu

Jana Narasimhan

Anuradha Bhattacharyya

Matthew G Woll

Anthony A Turpoff

Jigar S Patel

Scott J Barraza

Young-Choon Moon

Zhenrong Xu

Guangming Chen

Xiaoyan Zhang

Nanjing Zhang

Lukiana Amedzo

Wuming Yan

Aleksey I Gerasyuto

Hongyu Ren

Nadiya Sydorenko

Md Rauful Alam

Ramil Y Baiazitov

Michael Andrew Arnold

Christie Morrill

Nathaniel T Kenton

Sudipta Pal

Nicholas W Mszar

Tom Tuan Luong

Anthony Turpoff

Nicholas Walter Mszar

Gang Wang

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Compounds for treating Huntington's disease

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted benzothiazole compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Heteroaryl compounds for treating Huntington's disease

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heterocyclic and heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Heterocyclic and heteroaryl compounds for treating Huntington's disease

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I) or Formula (II), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. 

Growing community of inventors

Rahway, NJ, United States of America

Anthony R Mazzotti